Our data showed that the NSCLC cell line H-1299 can modulate CD1c+ DC subset development mediated by CD205 and CD103 when they are cocultured with DCs derived from NSCLC patients (Figure 2). The gene discussed is LY75; the disease is non-small cell lung carcinoma.